Abstract:Genomic surveillance of viral isolates during the 2013-2016 Ebola virus epidemic in Western Africa, the largest and most devastating filovirus outbreak on record, revealed several novel mutations. The responsible strain, named Makona, carries an A-to-V substitution at position 82 (A82V) in the glycoprotein (GP), which is associated with enhanced infectivity in vitro Here, we investigated the mechanistic basis for this enhancement as well as the interplay between A82V and a T-to-I substitution at residue 544 of GP, which also modulates infectivity in cell culture. We found that both 82V and 544I destabilize GP, with the residue at position 544 impacting overall stability, while 82V specifically destabilizes proteolytically cleaved GP. Both residues also promote faster kinetics of lipid mixing of the viral and host membranes in live cells, individually and in tandem, which correlates with faster times to fusion following colocalization with the viral receptor Niemann-Pick C1 (NPC1). Furthermore, GPs bearing 82V are more sensitive to proteolysis by cathepsin L (CatL), a key host factor for viral entry. Intriguingly, CatL processed 82V variant GPs to a novel product with a molecular weight of approximately 12,000 (12K), which we hypothesize corresponds to a form of GP that is pre-triggered for fusion. We thus propose a model in which 82V promotes more efficient GP processing by CatL, leading to faster viral fusion kinetics and higher levels of infectivity.IMPORTANCE The 2013-2016 outbreak of Ebola virus disease in West Africa demonstrated the potential for previously localized outbreaks to turn into regional, or even global, health emergencies. With over 28,000 cases and 11,000 confirmed deaths, this outbreak was over 50 times as large as any previously recorded. This outbreak also afforded the largest-ever collection of Ebola virus genomic sequence data, allowing new insights into viral transmission and evolution. Viral mutants arising during the outbreak have attracted attention for their potentially altered patterns of infectivity in cell culture, with potential, if unclear, implications for increased viral spread and/or virulence. Here, we report the properties of one such mutation in the viral glycoprotein, A82V, and its interplay with a previously described polymorphism at position 544. We show that mutations at both residues promote infection and fusion activation in cells but that A82V additionally leads to increased infectivity under cathepsin-limited conditions and the generation of a novel glycoprotein cleavage product.

Filovirus Glycoprotein Sequence, Structure and Virulence

The Lifecycle of the Ebola Virus in Host Cells.

Structural and Molecular Basis for Ebola Virus Neutralization by Protective Human Antibodies

Similarity is not enough: Tipping points of Ebola Zaire mortalities

Ebolavirus Classification Based on Natural Vectors

Molecular insights into the Ebola virus life cycle

A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion

Interplay Among Constitutes of Ebola Virus: Nucleoprotein, Polymerase L, Viral Proteins

Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity

The Ebola Virus Matrix Protein Penetrates into the Plasma Membrane

Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum

Molecular mechanisms of Ebola virus pathogenesis: focus on cell death

Structural basis of Ebola virus nucleocapsid assembly and functions

Intracellular Ebola Virus nucleocapsid assembly revealed by in situ cryo-electron tomography.

Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats

An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion

Fragment screening targeting Ebola virus nucleoprotein C-terminal domain identifies lead candidates

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion

Minor electrostatic changes robustly increase VP40 membrane binding, assembly, and budding of Ebola virus matrix protein derived virus-like particles

Non-Ebola Filoviruses: Potential Threats to Global Health Security

Resurgence of Ebola Virus: Transmission, Pathogenesis, Prevention and Cure